Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2019

Open Access 01-12-2019 | Doxycycline | Research article

Anti-borreliae efficacy of selected organic oils and fatty acids

Authors: Anna Goc, Aleksandra Niedzwiecki, Matthias Rath

Published in: BMC Complementary Medicine and Therapies | Issue 1/2019

Login to get access

Abstract

Background

Borrelia sp. is a causative pathogen of Lyme disease which has become a worldwide health concern. Non-toxic approaches especially directed toward latent persistent forms of this pathogen are desired. Lipids in the form of volatile and non-volatile oils, and fatty acids with proven anti-borreliae efficacy could become an additional support or an alternative for consideration in treatment approaches.

Methods

In this study we investigated 47 lipids (30 volatile and non-volatile oils, and 17 fatty acids) of plant and animal origin against typical motile, knob/round-shaped persisters, and biofilm-like aggregates of Borrelia burgdorferi s.s. and Borrelia garinii, which are identified as pathogenic factors of Lyme disease in the USA and Europe, using direct microscopic counting and spectrofluorometric measurements.

Results

Out of all examined lipids, 5 oils (Bay leaf oil, Birch oil, Cassia oil, Chamomile oil German, and Thyme oil) at or below 0.25%, and 3 fatty acids (13Z,16Z Docosadienoic acid, erucic acid, and petroselinic acid) at or below 0.75 mg/ml, showed bactericidal activity against typical motile spirochetes and knob/round-shaped persisters. Only Bay leaf oil and Cassia oil, including their major constituents, eugenol and cinnamaldehyde, showed to target biofilm-like aggregates of both tested Borrelia spp. at the same concentration, although with 20–30% eradication mark.

Conclusion

Based on obtained results, volatile oils were more potent than non-volatile oils, and unsaturated fatty acids were more effective than saturated fatty acids. Among all tested oils, Bay leaf oil and Cassia oil, with their major components eugenol and cinnamaldehyde, seem to have the highest anti-borreliae efficacy.
Literature
3.
go back to reference Brorson O, Brorson SH. In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium. Infection. 1998;26:144–50.CrossRef Brorson O, Brorson SH. In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium. Infection. 1998;26:144–50.CrossRef
4.
go back to reference Murgia R, Cinco M. Induction of cystic forms by different stress conditions in Borrelia burgdorferi. APMIS. 2004;112:57–62.CrossRef Murgia R, Cinco M. Induction of cystic forms by different stress conditions in Borrelia burgdorferi. APMIS. 2004;112:57–62.CrossRef
5.
go back to reference Sapi E, Bastian SL, Mpoy CM, Scott S, Rattelle A, Pabbati N, Poruri A, Burugu D, Theophilus PA, Pham TV, Datar A, Dhaliwal NK, MacDonald A, Rossi MJ, Sinha SK, Luecke DF. Characterization of biofilm formation by Borrelia burgdorferi in vitro. PLoS One. 2012;7:e48277.CrossRef Sapi E, Bastian SL, Mpoy CM, Scott S, Rattelle A, Pabbati N, Poruri A, Burugu D, Theophilus PA, Pham TV, Datar A, Dhaliwal NK, MacDonald A, Rossi MJ, Sinha SK, Luecke DF. Characterization of biofilm formation by Borrelia burgdorferi in vitro. PLoS One. 2012;7:e48277.CrossRef
6.
go back to reference Sapi E, Kaur N, Anyanwu S, Luecke DF, Datar A, Patel S, Rossi M, StrickeR RB. Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi. Infect Drug Resist. 2011;4:97–113.PubMedPubMedCentral Sapi E, Kaur N, Anyanwu S, Luecke DF, Datar A, Patel S, Rossi M, StrickeR RB. Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi. Infect Drug Resist. 2011;4:97–113.PubMedPubMedCentral
7.
go back to reference Sapi E, Balasubramanian K, Poruri A, Maghsoudlou JS, Socarras KM, Timmaraju AV, Filush KR, Gupta K, Shaikh S, Theophilus PA, Luecke DF, MacDonald A, Zelger B. Evidence of in vivo existence of Borrelia biofilm in Borrelial Lymphocytomas. Eur J Microbiol Immunol (Bp). 2016;6:9–24.CrossRef Sapi E, Balasubramanian K, Poruri A, Maghsoudlou JS, Socarras KM, Timmaraju AV, Filush KR, Gupta K, Shaikh S, Theophilus PA, Luecke DF, MacDonald A, Zelger B. Evidence of in vivo existence of Borrelia biofilm in Borrelial Lymphocytomas. Eur J Microbiol Immunol (Bp). 2016;6:9–24.CrossRef
8.
go back to reference Straubinger RK, Summers BA, Chang YF, Appel MJ. Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol. 1997;35:111–6.PubMedPubMedCentral Straubinger RK, Summers BA, Chang YF, Appel MJ. Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol. 1997;35:111–6.PubMedPubMedCentral
9.
go back to reference Embers ME, Barthold SW, Borda JT, Bowers L, Doyle L, Hodzic E, Jacobs MB, Hasenkampf NR, Martin DS, Narasimhan S, Phillippi-Falkenstein KM, Purcell JE, Ratterree MS, Philipp MT. Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. PLoS One. 2012;7:e29914.CrossRef Embers ME, Barthold SW, Borda JT, Bowers L, Doyle L, Hodzic E, Jacobs MB, Hasenkampf NR, Martin DS, Narasimhan S, Phillippi-Falkenstein KM, Purcell JE, Ratterree MS, Philipp MT. Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. PLoS One. 2012;7:e29914.CrossRef
10.
go back to reference Marques AS, Telford R, Turk SP, Chung E, Williams C, Dardick K, Krause PJ, Brandeburg C, Crowder CD, Carolan HE, Eshoo MW, Shaw PA, Hu LT. Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study. Clin Infect Dis. 2014;58:937–45.CrossRef Marques AS, Telford R, Turk SP, Chung E, Williams C, Dardick K, Krause PJ, Brandeburg C, Crowder CD, Carolan HE, Eshoo MW, Shaw PA, Hu LT. Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study. Clin Infect Dis. 2014;58:937–45.CrossRef
11.
go back to reference Lantos PM, Auwaerter PG, Wormser GP. A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease. Clin Infect Dis. 2014;58:663–71.CrossRef Lantos PM, Auwaerter PG, Wormser GP. A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease. Clin Infect Dis. 2014;58:663–71.CrossRef
12.
go back to reference Cameron DJ, Johnson L, Maloney EL. Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti-Infect Ther. 2014;12:1103–35.CrossRef Cameron DJ, Johnson L, Maloney EL. Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti-Infect Ther. 2014;12:1103–35.CrossRef
13.
go back to reference Klempner MS, Baker PJ, Shapiro ED, Marques A, Dattwyler RJ, Halperin JJ, Wormser GP. Treatment trials for post-Lyme disease symptoms revisited. Am J Med. 2013;126:665–9.CrossRef Klempner MS, Baker PJ, Shapiro ED, Marques A, Dattwyler RJ, Halperin JJ, Wormser GP. Treatment trials for post-Lyme disease symptoms revisited. Am J Med. 2013;126:665–9.CrossRef
14.
go back to reference Delong AK, Blossom B, Maloney EL, Phillips SE. Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials. Contemp Clin Trials. 2012;33:1132–42.CrossRef Delong AK, Blossom B, Maloney EL, Phillips SE. Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials. Contemp Clin Trials. 2012;33:1132–42.CrossRef
15.
go back to reference Fallon BA, Keilp JG, Corbera KM, Petkova E, Britton CB, Dwyer E, Slavov I, Cheng J, Dobkin J, Nelson DR, Sackeim HA. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70:992–1003.CrossRef Fallon BA, Keilp JG, Corbera KM, Petkova E, Britton CB, Dwyer E, Slavov I, Cheng J, Dobkin J, Nelson DR, Sackeim HA. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70:992–1003.CrossRef
16.
go back to reference Loewen PS, Marra CA, Marra F. Systematic review of the treatment of early Lyme disease. Drugs. 1999;57:157–73.CrossRef Loewen PS, Marra CA, Marra F. Systematic review of the treatment of early Lyme disease. Drugs. 1999;57:157–73.CrossRef
17.
go back to reference Barthold SW, Hodzic E, Imai DM, Feng S, Yang X, Luft BJ. Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrob Agents Chemother. 2010;54:643–51.CrossRef Barthold SW, Hodzic E, Imai DM, Feng S, Yang X, Luft BJ. Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrob Agents Chemother. 2010;54:643–51.CrossRef
18.
go back to reference Feng J, Zhang S, Shi W, Zhang Y. Ceftriaxone pulse dosing fails to eradicate biofilm-like microcolony B. Burgdorferi Persisters which are sterilized by Daptomycin/ doxycycline/cefuroxime without pulse dosing. Front Microbiol. 2016;7:1744–52.PubMedPubMedCentral Feng J, Zhang S, Shi W, Zhang Y. Ceftriaxone pulse dosing fails to eradicate biofilm-like microcolony B. Burgdorferi Persisters which are sterilized by Daptomycin/ doxycycline/cefuroxime without pulse dosing. Front Microbiol. 2016;7:1744–52.PubMedPubMedCentral
19.
go back to reference Sharma B, Brown AV, Matluck NE, Hu LT, Lewis K. Borrelia burgdorferi, the causative agent of Lyme disease, forms drug-tolerant persister cells. Antimicrob Agents Chemother. 2015;59:4616–24.CrossRef Sharma B, Brown AV, Matluck NE, Hu LT, Lewis K. Borrelia burgdorferi, the causative agent of Lyme disease, forms drug-tolerant persister cells. Antimicrob Agents Chemother. 2015;59:4616–24.CrossRef
20.
go back to reference Feng J, Auwaerter PG, Zhang Y. Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline. PLoS One. 2015;10:e0117207.CrossRef Feng J, Auwaerter PG, Zhang Y. Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline. PLoS One. 2015;10:e0117207.CrossRef
21.
go back to reference Aucott JN, Rebman AW, Crowder LA, Kortte KB. Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here? Qual Life Res. 2013;22:75–84.CrossRef Aucott JN, Rebman AW, Crowder LA, Kortte KB. Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here? Qual Life Res. 2013;22:75–84.CrossRef
22.
go back to reference Brorson O, Brorson SH. Grapefruit seed extract is a powerful in vitro agent against motile and cystic forms of Borrelia burgdorferi sensu lato. Infection. 2007;35:206–8.CrossRef Brorson O, Brorson SH. Grapefruit seed extract is a powerful in vitro agent against motile and cystic forms of Borrelia burgdorferi sensu lato. Infection. 2007;35:206–8.CrossRef
23.
go back to reference Liebold T, Straubinger RK, Rauwald HW. Growth inhibiting activity of lipophilic extracts from Dipsacus sylvestris Huds. Roots against Borrelia burgdorferi s. s. In vitro. Pharmazie. 2011;66:628–30.PubMed Liebold T, Straubinger RK, Rauwald HW. Growth inhibiting activity of lipophilic extracts from Dipsacus sylvestris Huds. Roots against Borrelia burgdorferi s. s. In vitro. Pharmazie. 2011;66:628–30.PubMed
24.
go back to reference Goc A, Niedzwiecki A, Rath M. In vitro evaluation of antibacterial activity of phytochemicals and micronutrients against Borrelia burgdorferi and Borrelia garinii. J Appl Microbiol. 2015;119:1561–72.CrossRef Goc A, Niedzwiecki A, Rath M. In vitro evaluation of antibacterial activity of phytochemicals and micronutrients against Borrelia burgdorferi and Borrelia garinii. J Appl Microbiol. 2015;119:1561–72.CrossRef
25.
go back to reference Goc A, Rath M. The anti-borreliae efficacy of phytochemicals and micronutrients: an update. Ther Adv Infect Dis. 2016;3:75–82.PubMedPubMedCentral Goc A, Rath M. The anti-borreliae efficacy of phytochemicals and micronutrients: an update. Ther Adv Infect Dis. 2016;3:75–82.PubMedPubMedCentral
26.
go back to reference Theophilus PA, Victoria MJ, Socarras KM, Filush KR, Gupta K, Luecke DF, Sapi E. Effectiveness of stevia Rebaudiana whole leaf extract against the various morphological forms of Borrelia Burgdorferi in vitro. Eur J Microbiol Immunol. (Bp). 2015;5:268–80.CrossRef Theophilus PA, Victoria MJ, Socarras KM, Filush KR, Gupta K, Luecke DF, Sapi E. Effectiveness of stevia Rebaudiana whole leaf extract against the various morphological forms of Borrelia Burgdorferi in vitro. Eur J Microbiol Immunol. (Bp). 2015;5:268–80.CrossRef
27.
go back to reference Feng J, Zhang S, Shi W, Zubcevik N, Miklossy J, Zhang T. Selective Essential Oils from Spice or Culinary Herbs Have High Activity against Stationary Phase and Biofilm Borrelia burgdorferi. Front Med. (Lausanne). 2017;4:169.CrossRef Feng J, Zhang S, Shi W, Zubcevik N, Miklossy J, Zhang T. Selective Essential Oils from Spice or Culinary Herbs Have High Activity against Stationary Phase and Biofilm Borrelia burgdorferi. Front Med. (Lausanne). 2017;4:169.CrossRef
28.
go back to reference Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev. 1999;12:564–82.CrossRef Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev. 1999;12:564–82.CrossRef
29.
go back to reference Morrison KC, Hergenrother PJ. Natural products as starting points for the synthesis of complex and diverse compounds. Nat Prod Rep. 2014;31:6–14.CrossRef Morrison KC, Hergenrother PJ. Natural products as starting points for the synthesis of complex and diverse compounds. Nat Prod Rep. 2014;31:6–14.CrossRef
30.
go back to reference Nazzaro F, Fratianni F, De Martino L, Coppola R, De Feo V. Effect of essential oils on pathogenic bacteria. Pharmaceuticals (Basel). 2013;6:1451–74.CrossRef Nazzaro F, Fratianni F, De Martino L, Coppola R, De Feo V. Effect of essential oils on pathogenic bacteria. Pharmaceuticals (Basel). 2013;6:1451–74.CrossRef
31.
go back to reference Chouhan S, Sharma K, Guleria S. Antimicrobial activity of some essential oils-present status and future perspectives. Medicines (Basel). 2017;4:E58.CrossRef Chouhan S, Sharma K, Guleria S. Antimicrobial activity of some essential oils-present status and future perspectives. Medicines (Basel). 2017;4:E58.CrossRef
32.
go back to reference Friedman M, Buick R, Elliott CT. Antibacterial activities of naturally occurring compounds against antibiotic-resistant Bacillus cereus vegetative cells and spores, Escherichia coli, and Staphylococcus aureus. J Food Prot. 2004;67:1774–8.CrossRef Friedman M, Buick R, Elliott CT. Antibacterial activities of naturally occurring compounds against antibiotic-resistant Bacillus cereus vegetative cells and spores, Escherichia coli, and Staphylococcus aureus. J Food Prot. 2004;67:1774–8.CrossRef
33.
go back to reference Maitland J, Fleming SA. Organic chemistry. United Kingdom: W. W. Norton & Co Inc (Np); 1998. Maitland J, Fleming SA. Organic chemistry. United Kingdom: W. W. Norton & Co Inc (Np); 1998.
34.
go back to reference Feng J, Wang T, Zhang S, Shi W, Zhang Y. An optimized SYBR green I/PI assay for rapid viability assessment and antibiotic susceptibility testing for Borrelia burgdorferi. PLoS One. 2014;9:e111809.CrossRef Feng J, Wang T, Zhang S, Shi W, Zhang Y. An optimized SYBR green I/PI assay for rapid viability assessment and antibiotic susceptibility testing for Borrelia burgdorferi. PLoS One. 2014;9:e111809.CrossRef
35.
go back to reference Singh O, Khanam Z, Misra N, Srivastava MK. Chamomile (Matricaria chamomilla L.): An overview. Appl Microbiol Biotechnol. 2010;85:1629–42.CrossRef Singh O, Khanam Z, Misra N, Srivastava MK. Chamomile (Matricaria chamomilla L.): An overview. Appl Microbiol Biotechnol. 2010;85:1629–42.CrossRef
36.
go back to reference Borugă O, Jianu C, Mişcă C, Goleţ I, Gruia AT, Horhat FG. Thymus vulgaris essential oil: chemical composition and antimicrobial activity. J Med Life. 2014;7:56–60.PubMedPubMedCentral Borugă O, Jianu C, Mişcă C, Goleţ I, Gruia AT, Horhat FG. Thymus vulgaris essential oil: chemical composition and antimicrobial activity. J Med Life. 2014;7:56–60.PubMedPubMedCentral
37.
go back to reference Tisserand R, Young R. Essential Oil Safety. United Kingdom: Churchill Livingstone Elsevier; 2013. Tisserand R, Young R. Essential Oil Safety. United Kingdom: Churchill Livingstone Elsevier; 2013.
38.
go back to reference McHale D, Laurie WA, Woof MA. Composition of west Indian bay oils. Food Chem. 1977;2:19–25.CrossRef McHale D, Laurie WA, Woof MA. Composition of west Indian bay oils. Food Chem. 1977;2:19–25.CrossRef
39.
go back to reference Ooi LS, Li Y, Kam SL, Wang H, Wong EY, Ooi VE. Antimicrobial activities of cinnamon oil and cinnamaldehyde from the Chinese medicinal herb Cinnamomum cassia Blume. Am J Chin Med. 2006;34:511–22.CrossRef Ooi LS, Li Y, Kam SL, Wang H, Wong EY, Ooi VE. Antimicrobial activities of cinnamon oil and cinnamaldehyde from the Chinese medicinal herb Cinnamomum cassia Blume. Am J Chin Med. 2006;34:511–22.CrossRef
40.
go back to reference Kabara JJ, Vrable R. Antimicrobial lipids: natural and synthetic fatty acids and monoglycerides. Lipids. 1977;12:753–9.CrossRef Kabara JJ, Vrable R. Antimicrobial lipids: natural and synthetic fatty acids and monoglycerides. Lipids. 1977;12:753–9.CrossRef
41.
go back to reference Kabara JJ, Swieczkowski DM, Conley AJ, Truant JP. Fatty acids and derivatives as antimicrobial agents. Antimicrob Agents Chemother. 1972;2:23–8.CrossRef Kabara JJ, Swieczkowski DM, Conley AJ, Truant JP. Fatty acids and derivatives as antimicrobial agents. Antimicrob Agents Chemother. 1972;2:23–8.CrossRef
42.
go back to reference Karbach J, Ebenezer S, Warnke PH, Behrens E, Al-Nawas B. Antimicrobial effect of Australian antibacterial essential oils as alternative to common antiseptic solutions against clinically relevant oral pathogens. Clin Lab. 2015;61:616–8.CrossRef Karbach J, Ebenezer S, Warnke PH, Behrens E, Al-Nawas B. Antimicrobial effect of Australian antibacterial essential oils as alternative to common antiseptic solutions against clinically relevant oral pathogens. Clin Lab. 2015;61:616–8.CrossRef
43.
go back to reference Martin KW, Ernst E. Herbal medicines for treatment of bacterial infections: a review of controlled clinical trials. J Antimicrob Chemother. 2003;51:241–6.CrossRef Martin KW, Ernst E. Herbal medicines for treatment of bacterial infections: a review of controlled clinical trials. J Antimicrob Chemother. 2003;51:241–6.CrossRef
44.
go back to reference Melo AD, Amaral AF, Schaefer G, Luciano FB, de Andrade C, Costa LB, Rostagno MH. Antimicrobial effect against different bacterial strains and bacterial adaptation to essential oils used as feed additives. Can J Microbiol. 2015;61:263–71.CrossRef Melo AD, Amaral AF, Schaefer G, Luciano FB, de Andrade C, Costa LB, Rostagno MH. Antimicrobial effect against different bacterial strains and bacterial adaptation to essential oils used as feed additives. Can J Microbiol. 2015;61:263–71.CrossRef
45.
go back to reference Leyva Salas M, Mounier J, Valence F, Coton M, Thierry A, Coton E. Antifungal microbial agents for food biopreservation-a review. Microorganisms. 2017;5:E37.CrossRef Leyva Salas M, Mounier J, Valence F, Coton M, Thierry A, Coton E. Antifungal microbial agents for food biopreservation-a review. Microorganisms. 2017;5:E37.CrossRef
46.
go back to reference Pisoschi AM, Pop A, Georgescu C, Turcuş V, Olah NK. Mathe EAn overview of natural antimicrobials role in food. Eur J Med Chem. 2018;143:922–35.CrossRef Pisoschi AM, Pop A, Georgescu C, Turcuş V, Olah NK. Mathe EAn overview of natural antimicrobials role in food. Eur J Med Chem. 2018;143:922–35.CrossRef
47.
go back to reference Draughon FA. Use of botanicals as biopreservatives in foods. Food Technol. 2004;58:20–8. Draughon FA. Use of botanicals as biopreservatives in foods. Food Technol. 2004;58:20–8.
48.
go back to reference Chaieb K, Hajlaoui H, Zmantar T, Kahla-Nakbi AB, Rouabhia M, Mahdouani K, Bakhrouf A. The chemical composition and biological activity of clove essential oil, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): a short review. Phytother Res. 2007;21:501–6.CrossRef Chaieb K, Hajlaoui H, Zmantar T, Kahla-Nakbi AB, Rouabhia M, Mahdouani K, Bakhrouf A. The chemical composition and biological activity of clove essential oil, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): a short review. Phytother Res. 2007;21:501–6.CrossRef
49.
go back to reference Yousef RT, Tawil GG. Antimicrobial activity of volatile oils. Pharmazie. 1980;35:698–701.PubMed Yousef RT, Tawil GG. Antimicrobial activity of volatile oils. Pharmazie. 1980;35:698–701.PubMed
50.
go back to reference Burt S. Essential oils: their antibacterial properties and potential applications in foods-a review. Int J Food Microbiol. 2004;94:223–53.CrossRef Burt S. Essential oils: their antibacterial properties and potential applications in foods-a review. Int J Food Microbiol. 2004;94:223–53.CrossRef
51.
go back to reference Smith-Palmer A, Stewart J, Fyfe L. Antimicrobial properties of plant essential oils and essences against five important food-borne pathogens. Lett Appl Microbiol. 1998;26:118–22.CrossRef Smith-Palmer A, Stewart J, Fyfe L. Antimicrobial properties of plant essential oils and essences against five important food-borne pathogens. Lett Appl Microbiol. 1998;26:118–22.CrossRef
52.
go back to reference Mayaud L, Carricajo A, Zhiri A, Aubert G. Comparison of bacteriostatic and bactericidal activity of 13 essential oils against strains with varying sensitivity to antibiotics. Lett Appl Microbiol. 2008;47:167–73.CrossRef Mayaud L, Carricajo A, Zhiri A, Aubert G. Comparison of bacteriostatic and bactericidal activity of 13 essential oils against strains with varying sensitivity to antibiotics. Lett Appl Microbiol. 2008;47:167–73.CrossRef
53.
go back to reference Devi KP, Sakthivel R, Nisha SA, Suganthy N, Pandian SK. Eugenol alters the integrity of cell membrane and acts against the nosocomial pathogen Proteus mirabilis. Arch Pharm Res. 2013;36:282–92.CrossRef Devi KP, Sakthivel R, Nisha SA, Suganthy N, Pandian SK. Eugenol alters the integrity of cell membrane and acts against the nosocomial pathogen Proteus mirabilis. Arch Pharm Res. 2013;36:282–92.CrossRef
54.
go back to reference Trinh NT, Dumas E, Thanh ML, Degraeve P, Ben Amara C, Gharsallaoui A, Oulahal N. Effect of a Vietnamese Cinnamomum cassia essential oil and its major component trans-cinnamaldehyde on the cell viability, membrane integrity, membrane fluidity, and proton motive force of Listeria innocua. Can J Microbiol. 2015;61:263–71.CrossRef Trinh NT, Dumas E, Thanh ML, Degraeve P, Ben Amara C, Gharsallaoui A, Oulahal N. Effect of a Vietnamese Cinnamomum cassia essential oil and its major component trans-cinnamaldehyde on the cell viability, membrane integrity, membrane fluidity, and proton motive force of Listeria innocua. Can J Microbiol. 2015;61:263–71.CrossRef
55.
go back to reference Cortés-Rojas DF, de Souza CR, Oliveira WP. Clove (Syzygium aromaticum): a precious spice. Asian Pac J Trop Biomed. 2014;4:90–6.CrossRef Cortés-Rojas DF, de Souza CR, Oliveira WP. Clove (Syzygium aromaticum): a precious spice. Asian Pac J Trop Biomed. 2014;4:90–6.CrossRef
56.
go back to reference Nabavi SF, Di Lorenzo A, Izadi M, Sobarzo-Sánchez E, Daglia M, Nabavi SM. Antibacterial effects of cinnamon: from farm to food, cosmetic and pharmaceutical industries. Nutrients. 2015;7:7729–48.CrossRef Nabavi SF, Di Lorenzo A, Izadi M, Sobarzo-Sánchez E, Daglia M, Nabavi SM. Antibacterial effects of cinnamon: from farm to food, cosmetic and pharmaceutical industries. Nutrients. 2015;7:7729–48.CrossRef
57.
go back to reference Jayaprakasha GK, Rao LJ. Chemistry, biogenesis, and biological activities of Cinnamomum zeylanicum. Crit Rev Food Sci Nutr. 2011;51:547–62.CrossRef Jayaprakasha GK, Rao LJ. Chemistry, biogenesis, and biological activities of Cinnamomum zeylanicum. Crit Rev Food Sci Nutr. 2011;51:547–62.CrossRef
58.
go back to reference Chen BJ, Fu CS, Li GH, Wang XN, Lou HX, Ren DM, Shen T. Cinnamaldehyde analogues as potential therapeutic agents. Mini Rev Med Chem. 2017;17:33–43.CrossRef Chen BJ, Fu CS, Li GH, Wang XN, Lou HX, Ren DM, Shen T. Cinnamaldehyde analogues as potential therapeutic agents. Mini Rev Med Chem. 2017;17:33–43.CrossRef
59.
go back to reference Desbois AP. Potential applications of antimicrobial fatty acids in medicine, agriculture and other industries. Recent Pat Antiinfect Drug Discov. 2012;7:111–22.CrossRef Desbois AP. Potential applications of antimicrobial fatty acids in medicine, agriculture and other industries. Recent Pat Antiinfect Drug Discov. 2012;7:111–22.CrossRef
60.
go back to reference Thormar H, Hilmarsson H. The role of microbicidal lipids in host defense against pathogens and their potential as therapeutic agents. Chem Phys Lipids. 2007;150:1–11.CrossRef Thormar H, Hilmarsson H. The role of microbicidal lipids in host defense against pathogens and their potential as therapeutic agents. Chem Phys Lipids. 2007;150:1–11.CrossRef
61.
go back to reference Freese E, Shew CW, Galliers E. Function of lipophilic acids as antimicrobial food additives. Nature. 1979;241:321–5.CrossRef Freese E, Shew CW, Galliers E. Function of lipophilic acids as antimicrobial food additives. Nature. 1979;241:321–5.CrossRef
62.
go back to reference Sun CQ, O’Connor CJ, Roberton AM. Antibacterial actionsof fatty acids and monoglycerides against helicobacter pylori. FEMS Immunol Med Microbiol. 2003;36:9–17.CrossRef Sun CQ, O’Connor CJ, Roberton AM. Antibacterial actionsof fatty acids and monoglycerides against helicobacter pylori. FEMS Immunol Med Microbiol. 2003;36:9–17.CrossRef
63.
go back to reference Desbois AP, Mearns-Spragg A, Smith VJ. A fatty acid from the diatom Phaeodactylumtricornutum is antibacterial against diverse bacteria including multi-resistant Staphylococcusaureus (MRSA). Mar Biotechnol. 2009;11:45–52.CrossRef Desbois AP, Mearns-Spragg A, Smith VJ. A fatty acid from the diatom Phaeodactylumtricornutum is antibacterial against diverse bacteria including multi-resistant Staphylococcusaureus (MRSA). Mar Biotechnol. 2009;11:45–52.CrossRef
64.
go back to reference Feldlaufer MF, Knox DA, Lusby WR, Shimanuki H. Antimicrobial activity of fatty acidsagainst Bacillus larvae, the causative agent of American foulbrood disease. Apidologie. 1993;24:95–9.CrossRef Feldlaufer MF, Knox DA, Lusby WR, Shimanuki H. Antimicrobial activity of fatty acidsagainst Bacillus larvae, the causative agent of American foulbrood disease. Apidologie. 1993;24:95–9.CrossRef
65.
go back to reference Seidel V, Taylor PW. In vitro activity of extracts and constituents of Pelagonium against rapidly growing mycobacteria. Int J Antimicrob Agents. 2004;23:613–9.CrossRef Seidel V, Taylor PW. In vitro activity of extracts and constituents of Pelagonium against rapidly growing mycobacteria. Int J Antimicrob Agents. 2004;23:613–9.CrossRef
66.
go back to reference Bergsson G, Arnfinnsson J, Steingrímsson Ó, Thormar H. Killing of gram-positive cocci by fatty acids and monoglycerides. APMIS. 2001;109:670–8.CrossRef Bergsson G, Arnfinnsson J, Steingrímsson Ó, Thormar H. Killing of gram-positive cocci by fatty acids and monoglycerides. APMIS. 2001;109:670–8.CrossRef
67.
go back to reference Heath RJ, White SW, Rock CO. Lipid biosynthesis as a target for antibacterial agents. Prog Lipid Res. 2001;40:467–97.CrossRef Heath RJ, White SW, Rock CO. Lipid biosynthesis as a target for antibacterial agents. Prog Lipid Res. 2001;40:467–97.CrossRef
68.
go back to reference Greenway DLA, Dyke KGH. Mechanism of the inhibitory action of linoleic acid on the growth of Staphylococcus aureus. J Gen Microbiol. 1979;115:233–45.CrossRef Greenway DLA, Dyke KGH. Mechanism of the inhibitory action of linoleic acid on the growth of Staphylococcus aureus. J Gen Microbiol. 1979;115:233–45.CrossRef
69.
go back to reference Schauenstein E. Autoxidation of polyunsaturated esters in water: chemical structure and biological activity of the products. J Lipid Res. 1967;8:417–28.PubMed Schauenstein E. Autoxidation of polyunsaturated esters in water: chemical structure and biological activity of the products. J Lipid Res. 1967;8:417–28.PubMed
Metadata
Title
Anti-borreliae efficacy of selected organic oils and fatty acids
Authors
Anna Goc
Aleksandra Niedzwiecki
Matthias Rath
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2019
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-019-2450-7

Other articles of this Issue 1/2019

BMC Complementary Medicine and Therapies 1/2019 Go to the issue